A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With R... by Beckermann, Kathryn E., MD, PhD, Bestvina, Christine M., MD, El Osta, Badi, MD, Sanborn, Rachel E., MD, Borghaei, Hossein, MD, Lammers, Philip Edward, MD, MSCI, Selvaggi, Giovanni, MD, Whisenant, Jennifer G., PhD, Heimann-Nichols, Ellen, MBA, Berry, Lynne, PhD, Hsu, Chih-Yuan, PhD, Shyr, Yu, PhD, Horn, Leora, MD, MSc, MHPE, Wakelee, Heather, MD, FASCO

Get full text

Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors by Myall, Nathaniel J., MD, Whisenant, Jennifer G., PhD, Neal, Joel W., MD, PhD, Iams, Wade T., MD, Reckamp, Karen L., MD, York, Sally, MD, PhD, Berry, Lynne D., PhD, Shyr, Yu, PhD, Horn, Leora, MD, Wakelee, Heather A., MD, Padda, Sukhmani K., MD

Get full text

Child Opportunity Index Disparities in Pediatric Surgical Encounters During the Coronavirus 2019 Pandemic by Berry, Jay G., MD, MPH, Ferrari, Lynne, MD, Ward, Valerie L., MD, MPH, Hall, Matt, PhD, Desmarais, Anna, BS, Raval, Mehul V., MD, MS, Tian, Yao, PhD, MPH, Mathieu, Derek, MBA, Incorvia, Joseph, MScGH, Meara, John G., MD, DMD, MBA

Get full text